04/08/2026
We're pleased to share this update from our friends at the NFED about the Edelife Clinical Trial, an international research study evaluating the first potential prenatal treatment for X-linked Hypohidrotic Ectodermal Dysplasia (XLHED) in baby boys.๐
Early results have been incredibly encouraging, with boys who received the treatment before birth now able to sweat.๐คฉ
The ED Society is proud to be involved in this important research by helping to raise awareness of the trial here in the UK and connecting eligible families with the research team.
A UK trial site is currently based in Cardiff, and if you or someone you know is affected by XLHED and may be planning a family, we'd love to hear from you.
If you'd like more information about the study, have any questions, or would like to find out whether you may be eligible, please get in touch with us.๐
Please take a look at the EDELIFE website - https://edelifeclinicaltrial.com/
Together, we hope research like this will continue to transform the future for families affected by Ectodermal Dysplasia. ๐
Jack is a shining hope for a future XLHED treatment! ๐
He is one of the many participants in the groundbreaking Edelife Clinical Trial for XLHED treatment, offering hope that Jack might develop the sweat glands that his grandfatherโand generations before himโnever had.
If you or someone you love is affected by XLHED and planning to have children, this FREE research study may be a treatment option for your child.
The Edelife Clinical Trial is evaluating the first potential prenatal treatment for XLHED in baby boys. In an earlier study, boys who received the treatment in-utero are now able to sweat, something many people with XLHED have never been able to do. All treatment and travel costs are covered.
Learn more about the study and see if you or someone you know may qualify at www.nfed.org/edelife